Insulin sensitive MHO-MetS patients showed a more favorable clinical and metabolic phenotype, not only when compared to MUO-MetS, but also in comparison with insulin resistant MHO-MetS (lower BMI z-score, WC, WtHR and leptin levels) (Table 5). The gene discussed is LEP; the disease is metabolic syndrome.